Squar Milner Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-23,854
Closed -$781K 130
2020
Q2
$781K Sell
23,854
-2,418
-9% -$77.2K 0.44% 58
2020
Q1
$790K Buy
26,272
+1,312
+5% +$39.1K 0.47% 34
2019
Q4
$722K Sell
24,960
-100
-0.4% -$2.77K 0.36% 52
2019
Q3
$870K Buy
25,060
+4,874
+24% +$123K 0.44% 59
2019
Q2
$515K Buy
20,186
+2,062
+11% +$51K 0.35% 62
2019
Q1
$474K Buy
18,124
+2,720
+18% +$66.8K 0.35% 64
2018
Q4
$355K Hold
15,404
0.34% 74
2018
Q3
$363K Buy
15,404
+870
+6% +$21.2K 0.33% 75
2018
Q2
$335K Hold
14,534
0.3% 89
2018
Q1
$358K Hold
14,534
0.45% 72
2017
Q4
$418K Buy
+14,534
New +$370K 0.51% 62

Other funds holding NVO

Squar Milner Financial Services's NVO Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 23,854 shares — an estimated $781K sold.

Squar Milner Financial Services first reported a position in NVO in Q4 2017 and held it in 11 quarters. The position peaked at $870K in Q3 2019. 660 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 23,854 Novo Nordisk shares in Q3 2020, an estimated $781K.
  • Squar Milner Financial Services first reported a position in Novo Nordisk in Q4 2017 and held it in 11 quarters.
  • Squar Milner Financial Services's Novo Nordisk position peaked at $870K in Q3 2019.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.